HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.

Abstract
5-Aminosalicylic acid (5-ASA), the presumed active moiety of sulfasalazine, has shown clinical efficacy when administered per rectum as initial therapy to patients with distal ulcerative colitis. We report the results of a randomized double-blind trial comparing nightly retention of a 4-g 5-ASA enema with continued administration of hydrocortisone enemas in 18 patients with persistent active distal ulcerative colitis after at least a 3-wk course of treatment with 100-mg hydrocortisone enemas with or without oral sulfasalazine. Continuation of hydrocortisone enemas rather than placebo was used in the control group to reflect the realistic alternative therapy likely to be employed in current practice. Response to therapy was assessed after 3 wk by comparing pretreatment and posttreatment point scores of clinical, sigmoidoscopic, and histological severity. Improvement in clinical score was achieved in seven of nine 5-ASA enema-treated patients versus one of nine hydrocortisone enema-treated patients (p less than 0.05). Sigmoidoscopic and histological improvement generally paralleled clinical improvement. We conclude that in patients with distal ulcerative colitis unresponsive to standard therapy, treatment with 5-ASA enemas results in significant short-term clinical and sigmoidoscopic improvement in a majority of cases. Moreover, a significantly greater number of refractory patients improve when switched to 5-ASA enemas than when continued on standard therapy.
AuthorsL S Friedman, J M Richter, S E Kirkham, H J DeMonaco, R J May
JournalThe American journal of gastroenterology (Am J Gastroenterol) Vol. 81 Issue 6 Pg. 412-8 (Jun 1986) ISSN: 0002-9270 [Print] United States
PMID3518408 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Aminosalicylic Acids
  • Mesalamine
  • Hydrocortisone
Topics
  • Adult
  • Aminosalicylic Acids (therapeutic use)
  • Clinical Trials as Topic
  • Colitis, Ulcerative (drug therapy)
  • Double-Blind Method
  • Drug Evaluation
  • Enema
  • Female
  • Humans
  • Hydrocortisone (therapeutic use)
  • Male
  • Mesalamine
  • Middle Aged
  • Occult Blood
  • Random Allocation
  • Sigmoidoscopy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: